CD184-FK506 ADC

N/A

Report date: 2024/02/05 14:05:25

Base Information

Drug NameCD184-FK506 ADC

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Tacrolimus payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionFK506-binding protein 1A degradersC-X-C motif chemokine receptor 4 antagonists

TargetsFK506-binding protein 1AC-X-C motif chemokine receptor 4

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmbrx Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAmbrx Inc

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A